Search

Bio-Rad Laboratories Inc

Fermé

SecteurSoins de santé

387.17 -0.69

Résumé

Variation du prix de l'action

24h

Actuel

Min

385.34

Max

388.53

Chiffres clés

By Trading Economics

Revenu

-2.3M

-13M

Ventes

59M

651M

P/E

Moyenne du Secteur

46.274

57.366

BPA

2.62

Marge bénéficiaire

-2.043

Employés

7,450

EBITDA

1.2B

542M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

-9.72% downside

Dividendes

By Acuity

Prochains Résultats

28 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.3B

10B

Ouverture précédente

387.86

Clôture précédente

387.17

Sentiment de l'Actualité

By Acuity

50%

50%

120 / 340 Classement par Healthcare

Bio-Rad Laboratories Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 août 2026, 20:08 UTC

News

Bio Rad Laboratories Inc shares are trading lower amid rising U.S. Treasury yields and broader market declines, closing near the lower end of their recent range.

26 août 2026, 19:16 UTC

News

Bio Rad Laboratories shares are lower despite Zacks raising its fiscal 2026 EPS estimate to $9.71, above the consensus of $9.14.

25 août 2026, 20:07 UTC

Bio Rad Laboratories Inc. shares are higher today, continuing a steady increase since Monday's close amid easing Treasury yields and falling oil prices.

24 août 2026, 19:25 UTC

Bio Rad Laboratories Inc shares are higher today, recovering from an early dip. The stock remains above its 20-day moving average.

22 août 2026, 00:02 UTC

Bio Rad Laboratories Inc shares are higher in after-market hours, reflecting a broader market rebound amid gains in major stocks like Tesla and UnitedHealth.

21 août 2026, 23:21 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher in after-market trading, influenced by Waters Corp's notable increase. Trading remains routine, with Bio Rad above its 20-day moving average.

20 août 2026, 23:41 UTC

Bio Rad Laboratories Inc shares are higher in after-market trading, recovering from an earlier dip. Declining jobless claims may support broader market sentiment.

19 août 2026, 20:03 UTC

Correlated Moves

Shares higher on strength in Life Sciences Tools & Services sector.

18 août 2026, 20:06 UTC

Bio Rad Laboratories Inc. is lower today, marking four consecutive daily declines. Rising U.S. Treasury yields amid inflation concerns contribute to the broader market context.

14 août 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, influenced by disappointing U.S. retail sales data that raised concerns about consumer demand and economic performance.

13 août 2026, 19:31 UTC

Bio Rad Laboratories Inc shares are declining today, influenced by significant downward movement in the Life Sciences Tools & Services sub-sector.

11 août 2026, 20:02 UTC

Bio Rad Laboratories Inc is trading higher, maintaining momentum after three consecutive gains. The price remains well above its 20-day moving average.

10 août 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, despite earlier gains. No specific news has been identified to explain the decline.

7 août 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

6 août 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are lower today, breaking a recent trend of gains. No specific news was identified to explain this decline.

5 août 2026, 20:03 UTC

News

Bio Rad Laboratories shares are higher as RBC raises its price target to $370. Wells Fargo and Citigroup also updated their price targets to $330.

4 août 2026, 22:02 UTC

News

Bio-Rad Laboratories shares are lower in after-market trading following a restructuring announcement and lowered full-year sales guidance despite strong second-quarter earnings.

3 août 2026, 19:46 UTC

Bio Rad Laboratories Inc is trading higher, supported by broader market trends amid falling oil prices. The stock remains near the upper end of its one-month range.

30 juil. 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29 juil. 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28 juil. 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27 juil. 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24 juil. 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23 juil. 2026, 20:03 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22 juil. 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21 juil. 2026, 16:26 UTC

News

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20 juil. 2026, 19:17 UTC

Correlated Moves

BIO shares lower; iShares U.S. Healthcare ETF declines during session.

Comparaison

Variation de prix

Bio-Rad Laboratories Inc prévision

Objectif de Prix

By TipRanks

-9.72% baisse

Prévisions sur 12 Mois

Moyen 350 USD  -9.72%

Haut 390 USD

Bas 330 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

1

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

120 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
help-icon Live chat